HUMA
(NASDAQ)Humacyte, Inc.
$0.64-- (--)
Loading... - Market loading
Humacyte (HUMA) Stock Price & Financial Analysis
Humacyte Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$0.64 - $0.71
52-Week High$2.84
52-Week Low$0.55
Open$0.64
Volume8.53M
Average Volume (3M)14.57M
Market Cap132.72M
Shares Outstanding197.85M
Price to Sales (P/S)64.73
Price to Book (P/B)11.23
EV/EBITDA-1.85
Revenue (TTM)2.02M
Net Income (TTM)-97.59M
Free Cash Flow (TTM)-102.38M
EPS (TTM)$-0.58
Profit Margin-4840.82%
Operating Margin-5649.21%
Return on Equity (ROE)-839.56%
Debt to Equity5.67
50-Day MA$0.97
200-Day MA$1.11
52-Week Change-72.74%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$0.64 - $0.71
52-Week High$2.84
52-Week Low$0.55
Open$0.64
Volume8.53M
Average Volume (3M)14.57M
Market Cap132.72M
Shares Outstanding197.85M
Price to Sales (P/S)64.73
Price to Book (P/B)11.23
EV/EBITDA-1.85
Revenue (TTM)2.02M
Net Income (TTM)-97.59M
Free Cash Flow (TTM)-102.38M
EPS (TTM)$-0.58
Profit Margin-4840.82%
Operating Margin-5649.21%
Return on Equity (ROE)-839.56%
Debt to Equity5.67
50-Day MA$0.97
200-Day MA$1.11
52-Week Change-72.74%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Humacyte
What is the current stock price for HUMA?
As of the latest trading session, HUMA stock trades at $0.67. The 52-week range is $0.55–$2.84, with a day range of $0.64–$0.71.
What is the P/E ratio for HUMA?
The P/E ratio (Price-to-Earnings) for HUMA is shown in the Key Statistics section. This valuation metric helps compare Humacyte, Inc. to industry peers.
Does HUMA pay dividends?
Humacyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HUMA?
Based on 7 analysts, the consensus for HUMA is Buy.
What is the market cap of HUMA?
Humacyte's market capitalization is $132.7M, classifying it as a micro-cap company. Humacyte operates in the Healthcare sector within the Biotechnology industry.